13F-HR and Genzyme

The 13F-HR filing for Carl Icahn was just posted on the SEC website (click: here). What’s interesting is that he started building a stake in Genzyme (Ticker: GENZ). As you have probably heard, the company encountered some setback due to a viral contamination and more recently particulate contamination in some products. The stock took a bit of a hit with the recent contamination news. Ok, back to Carl Icahn… As reported in the 13F-HR, he currently has 1,450,800 shares in Genzyme and I have to believe that he is continuing to build this position. Ralph Whitworth over at Relational Investors has 6,918,087 shares in Genzyme. Both of these guys are activist investors. Ralph Whitworth takes a longer term approach whereas Carl Icahn looks for a quick sale. The pressure is on Genzyme to do something quick to increase shareholder value or else someone else will do it for them.

Note: I have a long position in Genzyme.